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Polycomb group (PcG) proteins are major determi-
nants of gene silencing and epigenetic memory in
higher eukaryotes. Here, we systematically mapped
the human PcG complexome using a robust affinity
purification mass spectrometry approach. Our high-
density protein interaction network uncovered a
diverse range of PcG complexes. Moreover, our
analysis identified PcG interactors linking them to
the PcG system, thus providing insight into the
molecular function of PcG complexes and mecha-
nisms of recruitment to target genes. We identified
two human PRC2 complexes and two PR-DUB deu-
biquitination complexes, which contain the O-linked
N-acetylglucosamine transferase OGT1 and several
transcription factors. Finally, genome-wide profiling
of PR-DUB components indicated that the human
PR-DUB and PRC1 complexes bind distinct sets of
target genes, suggesting differential impact on
cellular processes in mammals.INTRODUCTION
Cell division requires faithful replication of the genome and resto-
ration of specific chromatin states that form the basis of epige-
netic memory (Sarkies and Sale, 2012). Polycomb group (PcG)
proteins were originally identified in Drosophila melanogaster
as stably maintaining the repressed state of homeotic genes
throughout development and are key players in this process.
Numerous studies have since established a central role for
PcG proteins in the dynamic control of hundreds of targets inC
This is an open access article under the CC BY-Nmetazoans, including genes affiliated to fundamental signaling
pathways (Ringrose, 2007). Biological processes regulated by
PcG proteins encompass cell differentiation, tissue regenera-
tion, and cancer cell growth (Jaenisch and Young, 2008; Maur-
ange et al., 2006; Sparmann and van Lohuizen, 2006).
The PcG system consists of multimeric repressive protein
complexes containing distinct chromatin modifying activities,
which impact transcriptional regulation bymodulating chromatin
structures. InDrosophila, five distinct PcG complexes displaying
different biochemical functions have been reported. The Poly-
comb repressive complex (PRC) 2 contains enhancer of zeste,
which trimethylates lysine 27 of histone H3 (H3K27me3) (Cao
et al., 2002; M€uller et al., 2002), while the PRC1 subunit Poly-
comb provides binding specificity to H3K27me3 through its
chromo-domain (Fischle et al., 2003; Min et al., 2003). PRC1
also contains the dRing protein, which catalyzes the mono-ubiq-
uitination of histone H2A on lysine 118 (H2AUb1), thereby block-
ing RNA polymerase II activity (de Napoles et al., 2004; Stock
et al., 2007; Wang et al., 2004). The Pleiohomeotic (Pho,
Drosophila homolog of mammalian YY1) repressive complex
PhoRC combines DNA- and histone tail-binding specificities
(Klymenko et al., 2006), the PRC1-related dRing-associated
factors complex (dRAF) contains the H3K36-specific histone de-
methylase dKDM2 (Lagarou et al., 2008), and the Polycomb
repressive deubiquitinase (PR-DUB) targets H2AUb1 (Scheuer-
mann et al., 2010).
Although the core components of Drosophila PcG complexes
seem fixed, we and others have shown that they can be co-pu-
rified with different sets of accessory proteins, thus increasing
the diversity of the PcG system (Furuyama et al., 2004; Klymenko
et al., 2006; Saurin et al., 2001; Str€ubbe et al., 2011). Epigenomic
profiling has revealed that distinct PcG complexes target largely
overlapping gene sets in Drosophila, and mechanistic details of
PcG recruitment to target genes are beginning to emerge (Beiselell Reports 17, 583–595, October 4, 2016 ª 2016 The Authors. 583
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Systematic Profiling of Human PcG Protein Complexes
(A)Workflow for nativeprotein complexpurifications fromFlp-InHEK293T-RExcells.Open reading framesof 64bait proteinswere cloned intoanexpressionvector
containing a tetracycline inducible CMV promoter, Strep-HA fusion tag, and FRT sites. The proteins were affinity purified from whole cell extracts of isogenic cell
lines, trypsinized, and identified by tandemmass spectrometry on an LTQOrbitrap XL. HCIPswere hierarchically clustered to infer protein complex compositions.
(B) Hierarchical clustering of HCIPs. Clusters of PcG and non-PcG complexes are labeled in red and blue, respectively. The inset shows the location of PRC1.1,
PRC1.3/PRC1.5, and the four core proteins RYBP/YAF2 and RING1/2. The clusters defined by single baits are indicated in green. Spearman’s rank correlation
coefficient based dissimilarities are color coded as indicated (top right).
(legend continued on next page)
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and Paro, 2011; Enderle et al., 2011; Oktaba et al., 2008;
Scheuermann et al., 2010; Schuettengruber et al., 2009).
In contrast, the mammalian PcG system is less well defined
and appears to be significantly more complex. Each Drosophila
PcG subunit has up to six human homologs, which combinatori-
ally assemble in different complexes (Gao et al., 2012; Mar-
gueron et al., 2008; Shen et al., 2008). The six homologs of the
Drosophila PRC1 core protein Psc, PCGF1–6, purify together
with RING2 (RNF2), the homolog of dRing, in different complexes
named PRC1.1–PRC1.6, and each of them associates with spe-
cific additional components (Gao et al., 2012; Sa´nchez et al.,
2007). These PRC1 complexes are further distinguished by the
mutually exclusive presence of RYBP or a chromo-domain-con-
taining CBX protein. There are five different CBX proteins dis-
playing differential affinities for lysine-methylated histone H3 tails
and RNA (Bernstein et al., 2006) that have been linked to PRC1.
In contrast, the absence of a chromo-domain within RYBP
suggests that recruitment of CBX and RYBP containing PRC1
complexes might be mediated by H3K27methylation or be inde-
pendent of it, respectively. Indeed, recent work showed that the
histone demethylase Kdm2b targets PRC1.1 (the dRAF analog)
via direct binding to unmethylated CpG islands (Farcas et al.,
2012; He et al., 2013; Wu et al., 2013). Incorporation of RING2
in optional PCGF complexes not only leads to differential recruit-
ment to chromatin, but also differentially regulates its enzymatic
activity (Farcas et al., 2012; Gao et al., 2012; Morey et al., 2012;
Tavares et al., 2012; Wu et al., 2013).
Similar to PRC1, the histone methyltransferase (HMT) activity
of PRC2 is potentially modulated by accessory components
such as the Polycomb-like homologs PHF1, PHF19, and MTF2
(Hunkapiller et al., 2012; Sarma et al., 2008). Additional DNA
binding interaction partners like JARD2 (JARID2) and AEBP2
might mediate recruitment of the complexes to chromatin (Kim
et al., 2003; Pasini et al., 2010; Peng et al., 2009; Shen et al.,
2009). Likewise, several interaction partners with chromatin
and DNA binding activity have been identified for BAP1 and
ASXL1/2, the human homologs of the Drosophila PR-DUB sub-
units (Baymaz et al., 2014; Dey et al., 2012; Ji et al., 2014). How-
ever, whether the PRC2 core, consisting of EED, SUZ12, and
EZH2, and the PR-DUB core, consisting of BAP1 and ASXL1
(and/or ASXL2), simultaneously interact with all of these compo-
nents or whether distinct complexes co-exist remains unknown.
Moreover, mammalian PhoRC has not been identified to date.
Understanding PcG-mediated epigenetic regulation in mam-
mals requires a detailed understanding of the dynamic assembly
of PcG complexes. A required step toward this goal is the
exhaustive definition of the composition of individual PcG com-
plexes including all accessory proteins, which likely convey
distinct functional effects. Here, we present a systematic and
comprehensive high-density map outlining the modular organi-
zation of the human PcG system using a sensitive double-affinity
purification and mass spectrometry (AP-MS) method (Glatter
et al., 2009; Varjosalo et al., 2013). The resulting map of 1,400 in-(C) Protein-protein interaction network of clustered interaction data. The blue li
hexagon-shaped nodes correspond to the baits used in this study.
(D and E) High-density interaction maps of PRC1.3/PRC1.5 (D) and PRC1.6 (E). T
represent baits; squares: identified HCIPs not used as baits in this study. Blackteractions and 490 proteins considerably refines the topology of
the human PRC1 and PRC2 network, including their relation with
the heterochromatin silencing system, and uncovers additional
interaction partners. Furthermore, we determined the composi-
tion of the human PR-DUB. We found that this highly diverse
complex contains MBD proteins, FOXK transcription factors,
and OGT1 (OGT), an O-linked N-acetylglucosamine (O-GlcNAC)
transferase implicated in PcG silencing in Drosophila (Gambetta
et al., 2009). Finally, chromatin profiling of PR-DUB components
and comparison with chromatin maps of PcG proteins indicate
that in contrast to Drosophila, PRC1 and PR-DUB regulate
distinct sets of genes in human cells.
RESULTS AND DISCUSSION
Systematic Mapping of the Human PcG Interaction
Proteome
To investigate the human PcG protein interaction network, we
applied a systematic proteomics approach, based on our previ-
ously reported AP-MS protocol in HEK293 cells (Glatter et al.,
2009). The method employs Flp-In HEK293 stable cell lines
expressing Strep-HA-tag fusion proteins upon tetracycline in-
duction (Figure 1A). Initially, we selected 28 PcG proteins homol-
ogous to Drosophila core complex components and performed
AP-MS experiments using these proteins as ‘‘primary baits’’ (Fig-
ure S1A). Then, based on the observed interaction data from this
set, we chose 36 additional ‘‘secondary bait’’ proteins (Fig-
ure S1A; Table S1). After double-affinity purification, bait-associ-
ated proteins (preys) were identified by liquid chromatography
(LC) tandem MS/MS (Figure 1A). At least two biological repli-
cates were measured for each bait protein, for a total of 174
AP-MS measurements. Proteins were identified using the
X!Tandem search tool to match mass spectra to peptides, and
the Trans-Proteomic Pipeline (TPP) to map peptides to proteins,
at a false discovery rate (FDR) of less than 1% (Craig and Beavis,
2004; Deutsch et al., 2010). The resulting raw data set contained
930 proteins exhibiting 9,856 candidate interactions.
To efficiently discriminate biologically relevant interaction
partners from contaminant proteins, we devised a stringent
filtering procedure based on both WDN-score (Behrends et al.,
2010) and average enrichment over control purifications for
each bait-prey pair (Tables S2 and S3). Interacting proteins
with WDN-score >1 and a control ratio >10 were considered
high confidence interacting proteins (HCIPs). This filtering
strategy retained 490 HCIPs, encompassing 1,400 (1,193 unidi-
rectional and 207 reciprocal) interactions. Our data set is charac-
terized by an average of 21.9 HCIPs per bait protein, with 75%of
interactions that have not yet been annotated in the IntAct data-
base (Figure S1B).
To evaluate the specificity and sensitivity of our AP-MS data,
we considered the two bait proteins exhibiting the highest num-
ber of HCIPs, SKP1 (79 HCIPs) and WDR5 (73), and performed a
cross-validation with literature-based reports. SKP1 serves asnes indicate interactions between proteins within the same cluster. Enlarged
he new subunits are highlighted by dashed boxes. The hexagon shaped nodes
nodes: common core subunits; yellow nodes: DNA binding proteins.
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an adaptor for F-Box proteins and CUL1 and confers enzymatic
specificity. Out of 79 HCIPs, our SKP1 purifications identified 42
F-Box proteins (Figure S1C). Furthermore, a previous AP-MS
study investigating the interaction partners of WDR5 (Cai et al.,
2010) identified a set of 21 proteins associating with this scaffold
protein, which takes part in the assembly of several chromatin-
regulating complexes (reviewed in Migliori et al., 2012). Notably,
while we were able to recall 76% of previously reported interac-
tion partners, our experiments identified an additional set of 48
proteins (Figure S1D) co-purifying with WDR5 and encompass-
ing MLL complexes, the NSL complex, the ADA2/GCN5/ADA3
transcription activator complex, mTORC2 components RICTR
(RICTOR) and SIN1 (MAPKAP1), and the Polycomb repressive
complex PRC1.6 (Figure S1E).
Hierarchical Clustering Assigns HCIPs to PcG
Complexes
To determine the topology of our protein interaction network, we
performed hierarchical clustering of HCIPs using a rank-based
correlation dissimilarity measure (see the Supplemental Informa-
tion for details). Clustering revealed a modular organization built
upon the three major PcG assemblies PRC1, PRC2, and PR-
DUB and HP1-associated complexes (Figures 1B and 1C).
PRC1 represents the most elaborate and heterogeneous
assembly, containing four groups of complexes defined by
the six PCGF proteins: PRC1.1 (PCGF1), PRC1.2/PRC1.4
(PCGF2/4), PRC1.3/PRC1.5 (PCGF3/5), and PRC1.6 (PCGF6).
Among these PRC1 assemblies, PRC1.6 further provides links
to the heterochromatin control system via the HP1 chromobox
proteins CBX1 and CBX3.
Although analysis of the PRC1 topology has been recently re-
ported in studies concentrating on specific subunits in various
cellular systems (Gao et al., 2012; van den Boom et al., 2013,
2016), our systematic high-density interaction data allowed us
to further refine the composition of the PRC1 module. In the
following discussion, we focus on themain aspects of this refine-
ment, which are illustrated in Figures 1B–1E and S3 and detailed
in Table S2.
All four PRC1 assemblies share a common core encompass-
ing the E3 ubiquitin ligases RING1 and RING2 and—with excep-
tion of PRC1.2/PRC1.4—RYBP and YAF2. Interestingly,
PCGF2/4 also interact with RYBP and YAF2. As these proteins
do not share any additional interaction partner besides
RING1/2 (Figure S3B), RYBP/YAF-PCGF2/4-RING complexes
might correspond to transient products before specific canoni-
cal and non-canonical PRC1 holo-complexes assemble.
Furthermore, we did not detect any protein stably associating
with all canonical PRC1 core members (RING1/2, PHC1–3,
CBX2/4/6/7/8, and PCGF2/4). However, we identified NUFP2
(nuclear fragile X mental retardation interacting protein 2,
NUFIP2), a putative RNA binding protein exhibiting interactions
with CBX2/6/7, PHC3, and PCGF4, as a PRC1 interacting pro-
tein (Figure S3B).
The PRC2 complex is separated from both PRC1 and HP1
(Figure 1C). The two characteristic histone binding proteins
RBBP4 and RBBP7 not only belong to the PRC2 core along
with SUZ12, EED, and EZH1/2, but also partake in other protein
complexes such as LINC, NURF, NURD, and SIN3 (Figure S2A).586 Cell Reports 17, 583–595, October 4, 2016Finally, we identified the PcG complex PR-DUB defined by
ASXL1/2 and BAP1 (Figure 1C). Our clustering analysis also re-
vealed complexes such as the TCP chaperonin and the protea-
somal lid, that primarily consist of prey proteins (Figure 1B). Of
note, several proteins belonging to MLL complexes share inter-
actions between PRC1.3/PRC1.5 (CSK21/22 [CSNK2A1/2]),
PRC1.6 (WDR5), and PR-DUB (OGT1) (Figure 1C). In contrast,
interaction modules centered on LMBL1/3/4 (L3MBTL1/3/4),
SUV92 (SUV39H2) and TRIPC (TRIP12), LCOR, ZN211
(ZNF211), and YY1 (the homolog of Drosophila Pho) are more
disconnected and tend to be sparse (Figures 1C, 2D, S2B, and
S2C). Although YY1 interacts with all subunits of the INO80 chro-
matin remodeling complex, our AP-MS data do not unveil an
equivalent of theDrosophila PhoRC complex (Figure S2B). How-
ever, except for PhoRC, we were able to reconstitute all
mammalian equivalents of Drosophila PcG protein assemblies
in detail.
WD40 Domain Proteins DCAF7 and WDR5 Are Central
Scaffolding Proteins for PRC1.3/PRC1.5 and PRC1.6
The WD40 domain protein DCAF7 has been implicated in skin
development and cell proliferation by interacting with DIAP1
(DIAPH1) and the dual-specificity tyrosine phosphorylation-
regulated kinase DYR1A (DYRK1A) (Miyata and Nishida, 2011).
Intriguingly, DCAF7 co-purified with CBX4/6/8, RING1/2,
RYBP/YAF2, and PCGF3/5/6, indicating that the protein is
deeply embedded in the PRC1 module. As recent studies also
reported interactions between DCAF7 and members of the ca-
nonical PRC1 complex, as well as PCGF3/5/6 (Dietrich et al.,
2012; El Messaoudi-Aubert et al., 2010; Sa´nchez et al., 2007;
Vandamme et al., 2011), we performed DCAF7 purifications to
test whether the protein is indeed a universal subunit of several
different RING1/2-containing complexes.
Our DCAF7 AP-MS revealed reciprocal interactions with all
bait proteins within a cluster centered on PCGF3 and 5 (Figures
1D and S3C), with no relation to the other PCGF complexes.
Moreover, we identified DYR1A/B, DIAP1, the zinc finger tran-
scription factors (ZNFs) ZN503 (ZNF503) and ZN703 (ZNF703),
and the ankyrin-repeat proteins SWAHA (SOWAHA) and
SWAHC (SOWAHC) as an unrelated module interacting with
DCAF7 (Figure 1D). This result suggests that DCAF7 acts as a
scaffold for several different protein complexes.
As for RING1/2, RYBP/YAF2, and PCGF3/5, DCAF7 interacts
with the tetrameric casein kinase 2 (CSK2) and the three paral-
ogs AUTS2, FBRS, and FBSL (FBRSL1). Therefore, to further
refine the PRC1.3/PRC1.5 subnetwork, we performed AP-MS
experiments using the catalytic casein kinase subunits CSK21
and CSK22. Our results confirmed the topology of the PCGF3/
5-DCAF7 assemblies and identify CSK2 and three uncharacter-
ized proteins within the AUTS2 family as part of PRC1.3/PRC1.5
(Figures 1D and S3C).
The protein PCGF6 was initially purified together with the tran-
scription factors E2F6, MAX, TFDP1, and MGAP (MGA), as well
as RING1/2, YAF2, LMBL2, CBX3, and the HMTs EHMT1 and
EHMT2, an assembly denoted as E2F6.com (Ogawa et al.,
2002). However, subsequent studies were unable to recover
the entire (holo) E2F6.com (Gao et al., 2012; Qin et al., 2012; Sa´n-
chez et al., 2007; Trojer et al., 2011). Moreover, recent data
suggest that PCGF6 and RING2 might interact with the WD40
domain protein WDR5 (Gao et al., 2012). We therefore decided
to revisit the topology of the PCGF6-E2F6 network and to probe
WDR5 connectivity by adding MAX, TFDP1, E2F6, LMBL2,
CBX3, EHMT2, and WDR5 to our bait collection. Our AP-MS
experiments unraveled a high-density network including recip-
rocal interactions between all but one (EHMT2) baits within this
set (Figures 1E and S2C), thus demonstrating that the major
PRC1.6 complex resembles E2F6.com. In addition, MGAP,
MAX, TFDP1, and E2F6 purifications revealed a rich set of tran-
scription factors that can heterodimerize with these proteins, but
that are not part of PRC1.6 as they did not connect to any other
component thereof (Figure 1E).
Recently, WDR5 was also reported to be part of the non-spe-
cific lethal (NSL) complex and to form a trimeric complex with
RBBP5 and ASH2L, which stimulates the H3K4-specific activity
of the SET1 HMT family members SET1A (SETD1A), SET1B
(SETD1B), and MLL1 (Cai et al., 2010; Dou et al., 2006; Wysocka
et al., 2006; Zhang et al., 2012). Interestingly, while we recalled
these interactions, we additionally detected reciprocal interac-
tions of WDR5 with all PRC1.6 subunits, thus demonstrating
thatWDR5 is a universal component of activating and repressing
chromatin-modifying complexes.
Taken together, our results identify the WD40 domain proteins
DCAF7 and WDR5 as subunits of PRC1.3/PRC1.5 and PRC1.6,
respectively. Importantly, recent studies suggested that the di-
versity of PRC1 complexes might be specified by binding prefer-
ences of PCGF proteins, which are mediated by their RING
finger- and WD40-associated ubiquitin-like (RAWUL) C-terminal
domain (Junco et al., 2013; Sanchez-Pulido et al., 2008). For
example, the PCGF1 and PCGF2/4 RAWUL domains selectively
interact with BCOR/BCORL (BCORL1) and PHC proteins,
respectively (Junco et al., 2013). Based on these analyses, and
since WD40 domain-containing proteins often scaffold multi-
subunit complexes (Migliori et al., 2012), we propose that
DCAF7 and WDR5 may serve as central scaffolding proteins
for PRC1.3/PRC1.5 and PRC1.6.
CBX1 Partitions in Several Distinct Heterochromatin
Complexes Including PRC1.6
In contrast to previous studies, which reported CBX3 as the only
heterochromatin protein within E2F6.com, we unexpectedly de-
tected CBX1 in all our PRC1.6-related pull-down experiments.
To corroborate this finding, we performed AP-MS experiments
with CBX1, using the constitutive heterochromatin protein
CBX5 as control. Our results indicate that while CBX5 is discon-
nected from the PCGF6-E2F6 network, components therein
interact with CBX1 (Figure 1E; Table S2). Furthermore, they vali-
date interactions of EHMT2with CBX1 and CBX3 and, to our sur-
prise, separate EHMT2 and EHMT1 from PRC1.6, suggesting a
separate complex containing CBX1/3, EHMT1/2, and ZNF pro-
teins, as well as the KRAB-ZNF interacting and co-repressor
protein TIF1B (TRIM28) (Figure S4A).
Given that the PcG and heterochromatin silencing systems are
functionally and molecularly related through PcG CBX2/4/6/7/8
and HP1 CBX1/3/5 proteins (reviewed in Beisel and Paro,
2011), we further explored the CBX1/3/5 core of our network,
seeking for potential connections between these two systems.This survey led to a refined topology of CBX1/3/5-containing
complexes and identified new interacting partners (Figures
S4B–S4E). However, we did not detect additional connections
to PcG proteins, suggesting limited direct cross-talk between
protein components of the two silencing systems.
The PRC2 Core Partitions into Two Different Classes of
Complexes
Although the functional core complex of PRC2 is composed of
SUZ12, EED, RBBP4/7, and either EZH1 or EZH2, additional
accessory proteins have been identified which may regulate
the H3K27 HMT activity of the complex and its recruitment to
chromatin (Alekseyenko et al., 2014; Kalb et al., 2014; Mar-
gueron and Reinberg, 2011). However, how these proteins are
organized within PRC2 or whether they assemble into indepen-
dent PRC2 subcomplexes remains largely unresolved. To
elucidate the topological organization of PRC2 complexes, we
performed AP-MS experiments using 14 reported PRC2-associ-
ated proteins (Figure S1A).
Hierarchical clustering analysis assigned all PRC2 baits to a
single cluster exhibiting high intra-cluster correlations (Figures
1B and 2A) and forming a high-density interaction network (Fig-
ure 2B). However, when reciprocal interactions were taken into
account, our data revealed two fundamental alternative assem-
blies linked to the PRC2 core, the first defined by AEBP2 and
JARD2 and the second by the mutually exclusive binding of
one of the three Polycomb-like homologs (PCLs) PHF1,
PHF19, and MTF2, respectively (Figure 2B).
Taken together, our results identify two structurally distinct
classes of PRC2 complexes. We therefore propose a consistent
nomenclature for PRC2, in which we refer to the two PRC2wings
as PRC2.1 (mutually exclusive interaction of PHF1, MTF2, or
PHF19) and PRC2.2 (simultaneous interaction of AEBP2 and
JARD2). AEBP2 and JARD2 can directly bind to DNA and have
been implicated in the recruitment of PRC2 and modulation of
its enzymatic activity (Kalb et al., 2014; Kim et al., 2009; Pasini
et al., 2010). Interestingly, depletion of JARD2 has only a mild ef-
fect on global H3K27methylation levels, suggesting that PRC2.1
might be primarily responsible for maintaining H3K27me3 pat-
terns genome wide.
C10ORF12 and C17ORF96 Are Mutually Exclusive
Subunits of the Polycomb-like Class of PRC2Complexes
Our purifications of the PRC2 core members and PCLs identified
two largely uncharacterized proteins, C10ORF12/LCOR and
C17ORF96 (Figure 2B), which have been recently discovered
as potential PRC2 components and co-localize on chromatin
with EZH2 (Alekseyenko et al., 2014; Maier et al., 2015; Smits
et al., 2013; Zhang et al., 2011). Their placement within the
PRC2 topology and their functional role remained unknown,
however.
Purifications of C17ORF96 confirmed all interactions with
PCLs (Figure 2B), and computational sequence analysis re-
vealed that C17ORF96 is present in all vertebrate genomes.
Interestingly, BLAST identified a single protein related to
C17ORF96 in the human genome, the SKI/DAC domain-contain-
ing protein 1 (SKDA1 [SKIDA1]) (Figure S5A). SKDA1 belongs
to the DACH family, which is defined by the presence ofCell Reports 17, 583–595, October 4, 2016 587
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Figure 2. High-Resolution Interaction Analysis Unravels Two Structurally Distinct Classes of PRC2 Complexes
(A) Excerpt of Figure 1B showing the PRC2 cluster.
(B) Interactionmap of PRC2 components. The PRC2 core is highlighted by a dashed box. The reciprocal interactions defining the two classes of PRC2 complexes
are indicated in red (PRC2.1) and blue (PRC2.2) edges. Orange edges: non-reciprocal interactions.
(C) Schematic representation of alternative protein isoforms of LCOR and C10ORF12. The numbers indicate amino acid positions.
(D) LCOR interaction map. Orange edges, interactions defined in this study; dashed edges, published interactions.
(E) Schematic representation of the employed luciferase reporter system. The amplicons (TSS, +500) used for ChIP-qPCR analysis are indicated.
(F) Anti-Gal4 western blot showing the expression of Gal4-C10ORF12 and Gal4-LCOR upon tetracycline induction.
(G) Luciferase activity of tetracycline-induced Gal4-C10ORF12 and Gal4-LCOR expressing cells, normalized to uninduced cells. The values are mean ± SD and
p values are from a two-sided t test (n = 7).
(H) Anti-Gal4 ChIP-qPCR analysis showing localization of C10ORF12 and LCOR to the reporter TSS.
(I) Anti-H3K27me3 ChIP-qPCR analysis at the reporter TSS upon C10ORF12 and LCOR expression. The values are mean ± SD and p values are from a two-sided
t test (n = 3).a SKI/SNO/DAC domain of about 100 amino acids, and is
involved in various aspects of cell proliferation and differentiation
(Caubit et al., 1999; Wu et al., 2007). However, C17ORF96 lacks
the SKI/SNO/DAC domain, and its homology to SKDA1 is
restricted to the C terminus (53% sequence identity within the
last 60 amino acids) (Figures S5A and S5B), suggesting that
this region encodes a hitherto uncharacterized protein domain.
Interestingly, SKDA1 also interacts with EZH1 and SUZ12 (Fig-
ure 2B), suggesting that this putative C-terminal domain medi-
ates the interaction of C17ORF96 and SKDA1 with the PRC2
core.
Initial analysis of C10ORF12, the second uncharacterized pro-
tein highly connected to the PRC2 core, identified peptides that
ambiguously mapped to two distinct UniProt proteins, LCOR
and C10ORF12 (Figures S5C–S5E). These two proteins are
encoded by the same genomic locus. Indeed, in contrast to
the UniProt database, GenBank contains the ligand-dependent
co-repressor, isoform CRA_b, EAW49962.1 (LCOR-Cra_b)
entry, where the N-terminal 111 amino acids of LCOR are fused
to C10ORF12, and the two regions are separated by a 200 amino588 Cell Reports 17, 583–595, October 4, 2016acid spacer (Figure 2C). LCOR is a ligand-dependent co-
repressor interacting via its N-terminal domain with nuclear hor-
mone receptors in a complex including CTBP and a number of
histone deacetylases (Fernandes et al., 2003; Shi et al., 2003).
Although our AP-MS analysis yielded peptides of the LCOR
N terminus, C10ORF12 and the LCOR-CRA_b specific spacer
(Figure S5C), peptides of the LCOR C terminus were missing
(Figure S5D), indicating that PRC2 interacts with LCOR-CRA_b
and potentially with the shorter isoform C10ORF12. To test this
possibility, we performed additional AP-MS experiments using
LCOR, C10ORF12, and LCOR-CRA_b as baits. LCOR purified
with its known interaction partners CTBP1 and CTBP2, while
PRC2 components were absent in LCOR purifications (Figures
2D and S5E). In contrast, both LCOR-CRA_b and C10ORF12
reciprocally interact with all subunits of the PCL wing of PRC2
(Figures 2B, S5D, and S5E).
To investigate the functional relevance of this finding, we
employed a heterologous reporter system based on a stably in-
tegrated, constitutively active luciferase reporter gene respon-
sive to upstream, promoter-proximal GAL4 DNA binding sites
AB
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Figure 3. Human PR-DUB Complexes
Contain OGT1 and FOXK Transcription
Factors
(A) Excerpt of Figure 1B showing the PR-DUB and
19S proteasome clusters.
(B) Topology of PR-DUB complexes. The in-
teractions of bait proteins with proteins localized in
PR-DUB cluster are indicated in blue. WDR5
shares many interacting proteins with OGT1
(indicated in red), which are predominantly MLL/
SET complex associated proteins and does not
interact with BAP1, ASXL1, and 2. Hexagons: bait
proteins; squares, identified HCIPs not used as
baits in this study. Yellow: FOXK1 and 2. Orange
nodes: OGT1 interactors. Dashed line: ASXL2-
MBD5 interaction, which was detected, but did
not pass our stringent filtering criteria.(Figure 2E) (Hansen et al., 2008). We engineered cell lines
containing tetracycline inducible GAL4-LCOR and GAL4-
C10ORF12 expression constructs, respectively. Upon induction,
both proteins accumulated in the nucleus and were recruited to
the GAL4 motifs, resulting in strong repression of luciferase ac-
tivity (Figures 2F–2H and S5F). To assess whether the repressive
activity of C10ORF12 is mediated by recruitment of PRC2 to the
target promoter, we performed chromatin immunoprecipitation
(ChIP) with an H3K27me3-specific antibody and analyzed the
enrichment of luciferase promoter fragments via qPCR. Upon
tetracycline induction, we found that the transcription start site
(TSS) of the luciferase gene was significantly trimethylated at
H3K27 in the GAL4-C10ORF12 expressing cell line (Figure 2I).
In contrast, despite that GAL4-LCOR was expressed at higher
levels than GAL4-C10ORF12 (Figure 2F) and exhibited a 10- to
20-fold increase in its binding to the reporter (Figure 2H), no sig-
nificant H3K27me3 enrichment was observed upon expression
of this protein.
PCL proteins target PRC2 and positively regulate its enzy-
matic activity via their ability to bind methylated H3K36 (Cai
et al., 2013; Musselman et al., 2012; Sarma et al., 2008).
However, further experimental investigation will be required toCellelucidate the exact mechanism by
which C17ORF96 and LCOR-CRA_b/
C10ORF12 influence PRC2.1. An inter-
esting possibility is that LCOR-CRA_b
recruits PRC2.1 to nuclear hormone re-
ceptor binding sites upon ligand binding.
This interaction, restricted to C10ORF12,
leaves the N terminus of LCOR free for
ligand responsive interaction with nuclear
hormone receptors.
ASXL1 and ASXL2 Define Optional
PR-DUB Complexes Containing
OGT1 and FOXK Transcription
Factors
The Drosophila PcG complex PR-DUB
was identified as a heterodimer consist-
ing of the deubiquitinase Calypso andthe Asx protein (Scheuermann et al., 2010). However, the
composition of its human counterpart remains elusive. Thus,
we set out to systematically characterize this complex by per-
forming purifications of BAP1, ASXL1, and ASXL2, the human
homologs of the Drosophila PR-DUB components. Our AP-MS
analysis revealed that BAP1 reciprocally interacts with both
ASXL1 and ASXL2 (Figure 3B). Interestingly, the two ASXL pro-
teins do not interact with each other (Figure 3B), suggesting
the existence of two mutually exclusive PR-DUB complexes,
which we called PR-DUB.1 and PR-DUB.2 depending on the
ASXL partner of BAP1 being ASXL1 and ASXL2, respectively.
Both PR-DUB core components share a similar set of acces-
sory proteins encompassing the transcription factors FOXK1
and FOXK2, the chromatin associated proteins MBD5 and
MBD6, the transcriptional co-regulator HCFC1, and most
notably OGT1 (Figure 3B). A recent attempt to identify BAP1
interaction partners led to the identification of Asxl1, Asxl2,
Ogt, Foxk1, Kdm1b, and Hcf1 in mouse spleen tissue (Dey
et al., 2012). Also, MDB5 andMBD6 have been shown to interact
with BAP1 and ASXL2 in HeLa and FOXK2 with BAP1 in U2OS
cells (Baymaz et al., 2014; Ji et al., 2014). Our data provide sup-
port to these results and indicate a general cell type independentReports 17, 583–595, October 4, 2016 589
assembly of mammalian PR-DUB complexes. Furthermore, our
data clearly implicate OGT1 as a member of mammalian PR-
DUB complexes, an interaction which was not identified in the
Drosophila PR-DUB complex purification (Scheuermann et al.,
2010), although the Drosophila homolog Ogt was previously
annotated as bona fide PcG protein (Gambetta et al., 2009).
OGT1 is the only O-GlcNAc transferase in mammals. The
enzyme catalyzes the addition of a single GlcNAc molecule to
serine and threonine of many target proteins (Hart et al., 2011).
OGT1 enzymatic activity is required for mouse development
and is essential for embryonic stem cell (ESC) viability (Vella
et al., 2013). In addition, the protein was found to interact with
BAP1 and to localize to chromatin via its interaction with the
5-methylcytosine oxidase TET1 (Dey et al., 2012; Vella et al.,
2013). To further refine the connectivity of OGT1 within the PR-
DUB network, we performed AP-MS experiments using OGT1
as bait.
This analysis validated the interaction between BAP1 and
OGT1 and the interactions of OGT1 with TET1 and NCOAT (Fig-
ure 3B), the O-GlcNAcase counteracting OGT1 activity (Vella
et al., 2013; Whisenhunt et al., 2006). Moreover, our data identi-
fied a second set of OGT1-containing complexes involved in
transcriptional regulation that did not co-purify with PR-DUB
core subunits (Figure 3B). These include the ZNFs ZEP1
(HIVEP1) and ZEP2 (HIVEP2) and the arginine-specific HMT
CARM1. Furthermore, we identified OGT1 as a subunit of
WDR5 containing complexes. Indeed, OGT1 exhibits interac-
tions with the NSL complex and with the SET1 HMT family acti-
vating complexWDR5/RBBP5/ASH2L, which is likely to mediate
the interaction of OGT1 with MLL1 and SET1A (Figure 3B).
Although no interaction of OGT1 with FOXK1/2 and MBD5/6
was detected, these proteins co-cluster with PR-DUB core com-
ponents and OGT1 is highly connected to the PR-DUB core (Fig-
ures 3A and 3B).
These results suggest that OGT1/HCFC1 and FOXK/MBD
proteins may form optional PR-DUB.1/PR-DUB.2 complexes.
Conversely, OGT1 interactions with FOXK and MBD proteins
could be transient and hence difficult to pinpoint by OGT1 affinity
purification.
Genomics Profiling of the FOXK1-Containing PR-DUB.1
A functional interaction of OGT1 with FOXK transcription factors
within the same PR-DUB complex would require their co-locali-
zation at genomic target sites. To test this hypothesis, we exam-
ined the genome-wide distribution of O-GlcNAc, a proxy for
catalytically active OGT1, ASXL1, and FOXK1 by performing
chromatin immunoprecipitation followed by Next Generation
Sequencing (ChIP-seq) in HEK293 cells (Figure S6A).
We found 41% and 55% of FOXK1 peaks co-localizing with
O-GlcNAc and ASXL1, respectively, while 69% of O-GlcNAc
peaks were co-occupied by ASXL1 (Figure 4A). In total, we iden-
tified 2,703 genomic loci bound by all three features (Figure 4A).
Functional annotation of these sites to genomic compartments
revealed a predominant binding of PR-DUB.1 to gene promoters
(Figure 4A), with read densities sharply peaking at TSSs of
RefSeq annotated genes (Figure 4B). Moreover, we found that
feature enrichments within ±1 kb of TSSs are highly correlated
to each other (p > 0.8), further indicating that ASXL1, FOXK1,590 Cell Reports 17, 583–595, October 4, 2016and OGT1 are likely subunits of the same protein complex (Fig-
ure 4C). To identify classes of genes bound by PR-DUB.1, we
subjected the set of TSSs bound by each complex member to
MSigDB pathway enrichment analysis. This analysis identified
highly overlapping sets of enriched pathways for each protein
(Figure S6B). Notably, PR-DUB.1 targets are predominantly en-
riched for genes involved in fundamental cellular processes like
gene expression, cell cycle, mitosis, and protein metabolism
(Figure 4D).
PRC1 Complexes and PR-DUB.1 Regulate Different
Target Genes
Mutations in Drosophila sxc (the gene encoding Ogt), calypso,
and Asx genes lead to derepression of HOX genes, and previous
studies reported a strong co-localization of PR-DUB and
O-GlcNAc with major PRC1 bound sites at inactive genes in
Drosophila (Gambetta et al., 2009; Scheuermann et al., 2010).
We sought to investigate this relation in the human genome by
comparing our PR-DUB profiles with publicly available ChIP-
seq data of RING2 and RYBP (Gao et al., 2012), as well as
TIF1B (Iyengar et al., 2011).
Our analysis therefore focused on six representatives of the
three major modules within our PcG interaction network at
the chromatin level: RING2 and RYBP, the central core of the
PRC1 module (Figure 1C), TIF1B, the common component of
ZNFs containing CBX1/3/5 complexes (Figure S4A), and PR-
DUB.1. Besides the expected high correlation between RING2
and RYBP (p = 0.78; Figure S6C), pairwise correlation analysis
of feature enrichments at promoters revealed a clear segregation
between PRC1 and TIF1B on the one hand and PR-DUB.1 on the
other hand (Figures 4E, 4F, and S6C). Similarly, when comparing
the genome-wide distribution of PR-DUB.1 (2,703 ASXL1+
GlcNAc+FOXK1 co-occupied regions) with ‘‘PRC1’’ (6,816
RING2+RYBP peaks) and TIF1B (10,297 peaks), we observed
only a partial co-localization of these three complexes at target
sites, with 24% and 31% of PR-DUB.1 binding sites co-bound
by PRC1 and TIF1B, respectively, and only 336 regions occupied
by all three complexes (Figure 4F).
In summary, our analysis uncovered the basic topology of the
human PR-DUB network at both the proteomics and genomics
level. Interestingly, and in contrast to Drosophila, the human
PR-DUB and PRC1 complexes bind largely distinct sets of
target genes, strongly suggesting they are involved in different
cellular processes in mammals. In addition, our AP-MS experi-
ments identified the transcription factors FOXK1 and FOXK2
as components of PR-DUB, hence highlighting a potential
recruitment mechanism of PR-DUB complexes and supporting
recent findings that FOXK2 can specifically target BAP1 to
chromatin (Ji et al., 2014). We anticipate that future experi-
ments based on our data will shed light on the functionality of
PR-DUB complexes in gene regulation and their relation to
PRC1 and PRC2.
Conclusions
Although considerable progress has been made in determining
the composition of mammalian PcG protein complexes, recent
findings are primarily based on studies of isolated protein
components in different cellular contexts with heterogeneous
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Figure 4. PR-DUB.1 and PRC1 Target Largely
Distinct Set of Genes
(A) Venn diagrams showing the genome-wide co-
localization of high-confidence peaks for the PR-
DUB.1 components FOXK1 (blue), ASXL1 (orange),
and the O-GlcNAc modification (green). The pie
chart illustrates the distribution of PR-DUB.1 peaks
(2,703, triple intersection) with respect to TSSs.
(B) Average ChIP-seq signal (normalized to total li-
brary size) of FOXK1, ASXL1, and O-GlcNAc within a
5 kb window centered on RefSeq TSS.
(C) Pairwise correlation of PR-DUB.1 feature en-
richments at TSSs. Spearman’s rank correlation co-
efficients are indicated.
(D) Functional annotation of high-confidence PR-
DUB.1 peaks localizing within 5 kb of annotated
TSSs. The top ten significantly enriched MSigDB
pathways are shown. UCSC tracks of PR-DUB.1
ChIP-seq signals at representative promoters
belonging to the top three categories are shown in
decreasing order of significance (blue tones).
(E) Heatmap of ChIP-seq signals (normalized to total
library size) for the indicated features within 10 kb of
PRC1 and PR-DUB.1 binding sites.
(F) Venn diagrams showing the genome-wide co-
localization of high-confidence PR-DUB.1 peaks
(red), PRC1 (brown), and TIF1B (light blue).
A representative UCSC track of ChIP-seq signals at
TSSs bound by all three features is shown.
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biochemical workflows, thus hampering a system-level under-
standing of gene silencing. In this study, in contrast, we used a
systematic proteomic approach to comprehensively map the
PcG protein interactome in a single human cell line. Since the
abundance of PcG proteins can vary between cell types and
surely influences the assembly of alternative protein complexes,
we chose HEK293 cells for our study as all PcG proteins are ex-
pressed in this cell type. The result is a high-density interaction
network, which enabled us to dissect individual PcG complexes
with unprecedented detail. By allocating newly identified interac-
tion partners to all PcG complex families and by identifying
candidate subunits responsible for complex targeting to chro-
matin, we obtained insights into molecular function and recruit-
ment of the PcG silencing system.
In addition to the fine mapping of the cardinal PcG complexes
PRC1 and PRC2, our data unravel human PR-DUB as amultifac-
eted assembly comprising OGT1 alongwith several transcription
and chromatin binding factors. Therefore, our study testifies
the significant diversity that exists among individual PcG com-
plexes in a single cell line. In addition, it provides a solid frame-
work for future systematic experiments aiming at disentangling
the biochemistry of PcG protein-mediated gene regulation in
mammalian cells.
EXPERIMENTAL PROCEDURES
Expression Constructs and Generation of Stable Cell Lines
To generate expression vectors for tetracycline-induced expression of
N-terminally SH-tagged bait proteins, human open reading frames (ORFs)
within pDONR223 vectors were picked from a Gateway-compatible human
orfeome collection (HORFeome v5.1, Open Biosystems) for LR recombina-
tion with the customized destination vector pcDNA5/FRT/TO/SH/GW,
which was obtained through ligation of the SH-tag coding sequence
and the Gateway recombination cassette into the polylinker of pcDNA5/
FTR/TO (Invitrogen). Genes not in the human orfeome collection were
amplified from human cDNA prepared from HEK293 cells by PCR and cloned
into entry vectors by TOPO (pENTR/D-TOPO) reaction. Stable Flp-In HEK293
T-REx cell lines were generated as described in the Supplemental
Information.
Protein Purification
Stable Flp-In HEK293 T-REx cell lines were grown in five 14.5 cm Greiner
dishes to 80% confluency and bait protein expression induced by the addition
of 1 mg/mL of tetracycline to the medium 16–24 hr prior to harvest in PBS con-
taining 1 mM EDTA. The suspended cells were pelleted and drained from the
supernatant for subsequent shock freezing in liquid nitrogen and long-term
storage at 80C.
The frozen cell pellets were resuspended in 5 mL TNN lysis buffer (100 mM
Tris [pH 8.0], 5 mMETDA, 250mMNaCl, 50 mMNaF, 1% Igepal CA-630 [Non-
idet P-40 Substitute], 1.5 mM Na3VO4, 1 mM PMSF, 1 mM DTT, and 13 Pro-
tease Inhibitor mix [Roche]) and rested on ice for 10 min. Insolubilizable
material was removed by centrifugation. Cleared lysates were loaded on a pre-
equilibrated spin column (Bio-Rad) containing 200 mL Strep-Tactin Sepharose
(IBA BioTAGnology). The Sepharose was washed four times with 1 mL TNN
lysis buffer (Igepal CA-630 and DTT concentrations adjusted to 0.5% and
0.5 mM, respectively). Bound proteins were eluted with 1 mL 2 mM biotin in
TNN lysis buffer (Igepal CA-630 and DTT concentrations adjusted to 0.5%
and 0.5 mM, respectively), incubated for 2 hr with 100 mL HA-Agarose (Sigma),
washed four times with TNN lysis buffer (Igepal CA-630 concentration
adjusted to 0.5%, w/o DTT and w/o protease inhibitors), and two additional
times in TNN buffer (100 mM Tris pH 8.0, 150 mM NaCl, and 50 mM NaF).
The bound proteins were released by acidic elution with 500 mL 0.2 M Glycine
pH 2.5 and the eluate was pH neutralized with NH4HCO3. Cysteine bonds were592 Cell Reports 17, 583–595, October 4, 2016reduced with 5 mM TCEP for 30 min at 37C and alkylated in 10 mM iodace-
tamide for 20min at room temperature in the dark. Samples were digestedwith
1 mg trypsin (Promega) overnight at 37C.
Bait proteins with low protein yield were processed by single step purifica-
tion, omitting the HA step. The frozen cell pellets were resuspended in 5 mL of
TNN lysis buffer containing 10 mg/mL avidin. The eluates were TCA precipi-
tated to remove biotin and resolubilized in 50 mL 10% ACN, 50 mM NH4HCO3
pH 8.8. After dilution with NH4HCO3 to 5% ACN, the samples were reduced,
alkylated, and digested as in the double step protocol.
The digested peptides were purified with C18 MicroSpin columns (The Nest
Group) according to the protocol of the manufacturer, resolved in 0.1% formic
acid, and 1% acetonitrile for mass spectrometry analysis.
Mass Spectrometry
LC-MS/MS analysis was performed on an LTQ Orbitrap XL mass spectrom-
eter (Thermo Fisher Scientific). Peptide separation was carried out by reverse
phase on a Proxeon EASY-nLC II liquid chromatography system (Thermo
Fisher Scientific). The reverse phase column (75 mm 3 10 cm) was packed
with Magic C18 AQ (3 mm) resin (WICOM International). A linear gradient
from 5% to 35% acetonitrile in 0.1% formic acid was run for 60 min at a
flow rate of 300 nL/min. Data acquisition was set to obtain one high resolu-
tion MS scan in the Orbitrap (60,000 at 400 m/z) followed by six collision-
induced fragmentation (CID) MS/MS fragment ion spectra in the linear trap
quadrupole (LTQ). Orbitrap charge state screening was enabled and ions
with unassigned or single charge states were rejected. The dynamic exclu-
sion window was set to 15 s and limited to 300 entries. The minimal precur-
sor ion current to trigger CID and MS/MS scan was set to 150. The ion
accumulation time was set to 500 ms (MS) and 250 ms (MS/MS) using a
target setting of 106 (MS) and 104 (MS/MS) ions. After every replicate series,
a peptide reference sample containing 200 fmol of human [Glu1]-Fibrinopep-
tide B (Sigma-Aldrich) was analyzed to monitor the overall LC-MS/MS sys-
tems performance.
ChIP and Preparation of ChIP-Seq Libraries
Chromatin fixation and immunoprecipitation were performed essentially as
described (Orlando et al., 1997). Cells (3–43 108) were fixed in 200 mL of me-
dium with 1% formaldehyde for 10 min at room temperature. Cross-linked
cells were sonicated to produce chromatin fragments of an average size of
150–400 bp. Soluble chromatin was separated from insoluble material by
centrifugation. The supernatant containing chromatin of 1–2 3 107 cells was
used for immunoprecipitation. Sequencing libraries were prepared with the
NEB Genomic DNA Sample Preparation Kit according to NEB’s instructions.
After adaptor ligation, library fragments of 250–350 bp were isolated from an
agarose gel. The DNA was PCR amplified with Illumina primers with 18 cycles,
purified, and loaded on an Illumina flow cell for cluster generation. Libraries
were sequenced on the Genome Analyzer IIx (TrueSeq cBot-GA v2 and
TruSeq v5 SBS Kit) and HiSeq 2000 (HiSeq Flow Cell v3 and TruSeq SBS
Kit v3) following the manufacturer’s protocols.
For ChIP-qPCR, nuclei were prepared essentially as described in ‘‘Func-
tional Analysis of DNA and Chromatin’’ (Santoro, 2014). Immunoprecipitations
were performed using Anti-GAL4 (sc-510, Santa Cruz Biotechnology), Anti-
IgG (10500C, Invitrogen), and Anti-H3K27me3 kindly provided by Thomas
Jenuwein. Anti-FOXK1 (ab18196) was purchased from Abcam, Anti-ASXL1
(sc85283) from Santa Cruz Biotechnology, and Anti-GlcNAc (HGAC85) from
Novus Biologicals. Primer sets used for qPCR are listed in the Supplemental
Information.
Data Analysis
Description of data processing and analysis methods are available in the Sup-
plemental Information.
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